Case Report
BibTex RIS Cite

BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria

Year 2017, Volume: 7 Issue: 4, 93 - 95, 13.12.2017

Abstract

Bupropion depresyon ve sigara bırakma tedavisinde kullanılan, norepinefrin ve dopamin geri

alım inhibitörüdür. 1997 yılında ABD Gıda ve İlaç İdaresi (FDA) tarafından sigara bırakma tedavisinde

onaylanmıştır. Bupropion, bu endikasyonda Zyban ticari ismiyle sürekli salınımlı bir ürün

olarak formüle edilmiştir. En sık görülen yan etkiler iştahsızlık, ağız kuruluğu, uykusuzluk, baş

ağrısı ve kabızlıktır. Bupropion ayrıca jeneralize akut ürtiker ve anjioödemi indükleyebilir. Bupropiyon

kaynaklı ürtikere bazen anjioödem, artralji, serum benzeri reaksiyon veya anafilaksi belirtileri

eşlik eder. Burada, sigara bırakmak için bupropiyon kullanımının neden olduğu bir jeneralize

akut ürtiker olgusunu sunuyoruz.

Anahtar Sözcu¨kler: Bupropion; Ürtiker; Kutanöz ilaç reaksiyonu


ABSTRACT

Bupropion is a norepinephrine and dopamine reuptake inhibitor used to treat depression and

for smoking cessation. It was approved by the U.S. Food and Drug Administration (FDA) for use

as a smoking cessation in 1997. Bupropion was formulated for this indication as a sustainedrelease

product marketed under the brand name Zyban. The most common side effects are loss

of appetite, dry mouth, insomnia, headache and constipation. Bupropion may also induce generalized

acute urticaria and angioedema. Bupropion-induced urticaria is sometimes accompanied

by angioedema, arthralgia, serum-like reaction or symptoms of anaphylaxis. We report a case of

generalized acute urticaria caused by bupropion used for smoking cessation.

Keywords: Bupropion; Urticaria; Cutaneous drug reaction

References

  • 1. Hu LY, Liu CJ, Lu T, Hu TM, Tsai CF, Hu YW, et al. Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study. 2013;8:e80064. 2. Crain D, Bhat A. Current treatment options in smoking cessation. Hosp Pract(1995). 2010 ;38:53-61. 3. Tackett AE, Smith KM. Bupropion-induced angioedema. Am J Health Syst Pharm. 2008;65:1627-1630. 4. Beyens MN, Guy C, Mounier G, Laporte S, Ollagnier M. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf. 2008;31:1017-1026. 5. Cooper KD. Urticaria and angioedema: diagnosis and evaluation. J Am Acad Dermatol. 1991;25:166-174; discussion 174-176. Review. 6. Fays S, Tréchot P, Schmutz JL, Cuny JF, Truchetet F, Barbaud A. Bupropion and generalized acute urticaria: eight cases. Br J Dermatol. 2003;148:177-178. 7. Tuman TC, Tuman BA, Göksügür N, Kayka N, Yıldırım O. Urticaria and Angioedema Associated With Bupropion: Three Cases. Prim Care Companion CNS Disord. 2016;18(4). 8. Mitkov MV, Trowbridge RM, Lockshin BN, Caplan JP. Dermatologic side effects of psychotropic medications. Psychosomatics. 2014;55:1-20.
Year 2017, Volume: 7 Issue: 4, 93 - 95, 13.12.2017

Abstract

References

  • 1. Hu LY, Liu CJ, Lu T, Hu TM, Tsai CF, Hu YW, et al. Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study. 2013;8:e80064. 2. Crain D, Bhat A. Current treatment options in smoking cessation. Hosp Pract(1995). 2010 ;38:53-61. 3. Tackett AE, Smith KM. Bupropion-induced angioedema. Am J Health Syst Pharm. 2008;65:1627-1630. 4. Beyens MN, Guy C, Mounier G, Laporte S, Ollagnier M. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf. 2008;31:1017-1026. 5. Cooper KD. Urticaria and angioedema: diagnosis and evaluation. J Am Acad Dermatol. 1991;25:166-174; discussion 174-176. Review. 6. Fays S, Tréchot P, Schmutz JL, Cuny JF, Truchetet F, Barbaud A. Bupropion and generalized acute urticaria: eight cases. Br J Dermatol. 2003;148:177-178. 7. Tuman TC, Tuman BA, Göksügür N, Kayka N, Yıldırım O. Urticaria and Angioedema Associated With Bupropion: Three Cases. Prim Care Companion CNS Disord. 2016;18(4). 8. Mitkov MV, Trowbridge RM, Lockshin BN, Caplan JP. Dermatologic side effects of psychotropic medications. Psychosomatics. 2014;55:1-20.
There are 1 citations in total.

Details

Journal Section Case Report
Authors

Gülhan Gürel

Emine Çölgeçen This is me

Publication Date December 13, 2017
Published in Issue Year 2017 Volume: 7 Issue: 4

Cite

APA Gürel, G., & Çölgeçen, E. (2017). BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria. Bozok Tıp Dergisi, 7(4), 93-95.
AMA Gürel G, Çölgeçen E. BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria. Bozok Tıp Dergisi. December 2017;7(4):93-95.
Chicago Gürel, Gülhan, and Emine Çölgeçen. “BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria”. Bozok Tıp Dergisi 7, no. 4 (December 2017): 93-95.
EndNote Gürel G, Çölgeçen E (December 1, 2017) BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria. Bozok Tıp Dergisi 7 4 93–95.
IEEE G. Gürel and E. Çölgeçen, “BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria”, Bozok Tıp Dergisi, vol. 7, no. 4, pp. 93–95, 2017.
ISNAD Gürel, Gülhan - Çölgeçen, Emine. “BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria”. Bozok Tıp Dergisi 7/4 (December 2017), 93-95.
JAMA Gürel G, Çölgeçen E. BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria. Bozok Tıp Dergisi. 2017;7:93–95.
MLA Gürel, Gülhan and Emine Çölgeçen. “BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria”. Bozok Tıp Dergisi, vol. 7, no. 4, 2017, pp. 93-95.
Vancouver Gürel G, Çölgeçen E. BUPROPİONA BAĞLI JENERALİZE AKUT ÜRTİKER Bupropion – Induced Generalized Acute Urticaria. Bozok Tıp Dergisi. 2017;7(4):93-5.
Copyright © BOZOK Üniversitesi - Tıp Fakültesi